Rheumatology fellow Rachel Wallwork discusses her latest research results on how an antibody in systemic sclerosis patients with cancer may be a key biomarker to predict possible cancer development.
Bladder Cancer in Women | Q&A with A Urologic Oncologist
Prenatal phenotype of 47, XXY (Klinefelter syndrome)
CNS Guidelines for the Operative and Nonoperative Management of Patients with Chiari Malformation
Diagnosing and Treating Clubfoot in Children
Improved Overall Survival in Patients with Lung Cancer and Autoimmune Rheumatic Diseases
Anti-vinculin Antibodies in Systemic Sclerosis: Associations with Slow Gastric Transit and Extra-Intestinal Clinical Phenotype
Skeletal Myopathy in Systemic Sclerosis Associated with Higher Disease Burden and Mortality
Change in Urinary Biomarkers at Three Months Predicts 1-year Treatment Response of Lupus Nephritis Better than Proteinuria
Chimeric autoantigen-T cell receptor (CATCR)-T cell therapies to selectively target autoreactive B cells
Detecting the Tumor — How Noninvasive Diagnostic Testing Is Shaping the Future of Neuro-oncology
Management of Complex Tethered Cord in Transitional and Adult Patients: Spinal Cord Shortening, Spinal Cord Stimulation, or Repeat Intradural Repair?
Cerebrospinal Fluid Drainage in Acute Spinal Cord Injury: A Multi-Center, Randomized, Controlled Trial
Diabetes & Endocrinology
person Sign In / Create Account